An interventional study of Web-Based End-of-Life and Post-Mortem Care Education and Face-to-Face Case Discussion Sessions in End-of-Life and Post-Mortem Care Education, sponsored by Necmettin Erbakan University. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-04.
Sponsored by Necmettin Erbakan University · Not applicable, Interventional, and Other
This study aims to evaluate the effect of a web-based end-of-life and post-mortem care education program on nursing students' post-mortem self-efficacy, death literacy, and attitudes toward the principles of a dignified death. Participants will receive educational content through an online learning platform, and the effectiveness of the program will be assessed using validated questionnaires administered before and after the intervention. The findings are expected to support the development of accessible, sustainable, and effective digital education programs that enhance nursing students' knowledge, skills, and attitudes related to end-of-life and post-mortem care.
This study is designed as a single-blind, parallel-group randomized controlled trial to evaluate the effectiveness of a web-based end-of-life and post-mortem care education program developed for undergraduate nursing students. The educational intervention has been developed as part of a doctoral dissertation and is based on current scientific evidence, international recommendations, and the End-of-Life Nursing Education Consortium (ELNEC) curriculum.
The intervention consists of eight structured online learning modules covering the fundamental concepts of end-of-life care, symptom management, recognition of the dying process, principles of a dignified death, post-mortem care practices, family support, spiritual care, and case-based learning. Each module is designed to be completed within approximately 10-15 minutes and includes narrated presentations, visual materials, flowcharts, decision trees, animations, and case-based learning activities. The educational videos will be delivered through a dedicated web-based learning platform that allows participants to access the content regardless of time and location. The platform will ensure sequential completion of the modules; participants will not be able to fast-forward videos or proceed to the next module without completing the current one.
Participants randomized to the intervention group will receive the web-based educational program through the online learning platform over a two-month period. Participants randomized to the control group will participate in three face-to-face case discussion sessions covering end-of-life and post-mortem care as specified in the study protocol. To minimize contamination between the study groups, participants in the control group will not have access to the web-based educational platform during the intervention period. After completion of data collection, the web-based educational materials will also be made available to participants in the control group.
Before implementation, the educational materials will undergo expert review to establish content validity. Subsequently, a pilot study will be conducted with nursing graduates to evaluate the usability of the web platform and the comprehensibility of the educational content. Feedback obtained during the pilot phase will be incorporated into the final version of the educational program before participant recruitment begins.
Participants will be allocated to the study groups using a computer-generated randomization procedure conducted by an independent researcher who is not involved in the implementation of the study. To ensure comparability between groups, randomization will be performed while considering participants' grade point averages. Because the educational intervention will be delivered by the principal investigator, investigator blinding will not be feasible. However, participants will not be informed of their group allocation, and the researchers responsible for outcome assessment, data coding, and statistical analyses will remain blinded to group assignment. The study will be conducted and reported in accordance with the CONSORT 2025 Statement: Updated Guideline for Reporting Randomized Trials.
The web-based education platform has been specifically designed for this study to provide flexible access to educational materials while enabling standardized delivery of the intervention. The platform includes secure individual user accounts, participant progress monitoring, reminder functions, and restricted access limited to enrolled participants. These features are intended to improve participant adherence and ensure consistent implementation of the educational intervention throughout the study.
456 studies on the registry are indexed under Death; 86 are open to participants now.
This study's planned enrollment of 74 is below the median of 163 across 210 interventional studies indexed under Death.
Browse Death studies →Necmettin Erbakan University is the lead sponsor of 201 studies on the registry; 48 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants assigned to the experimental group will receive a web-based end-of-life and post-mortem care education program consisting of eight structured online modules delivered over a two-month period. The educational content is provided through a dedicated web-based learning platform that allows participants to access the modules asynchronously while ensuring sequential completion of all learning activities.
Behavioral: Web-Based End-of-Life and Post-Mortem Care Education
Participants assigned to the control group will participate in three face-to-face case discussion sessions covering end-of-life and post-mortem care topics according to the study protocol. Access to the web-based educational program will be withheld during the intervention period and will be provided after completion of data collection.
Behavioral: Face-to-Face Case Discussion Sessions
Participants assigned to the experimental group will receive a web-based educational program consisting of eight structured online modules covering end-of-life and post-mortem care. The program is delivered through a dedicated web-based learning platform and includes narrated presentations, visual materials, case-based learning activities, and interactive educational resources. The intervention is designed to be completed over a two-month period, with sequential access to the modules to ensure completion of all educational content.
Participants assigned to the control group will participate in three face-to-face case discussion sessions focusing on end-of-life and post-mortem care according to the study protocol. During the intervention period, participants in the control group will not have access to the web-based educational platform. After completion of data collection, access to the web-based educational materials will be provided.
Post-Mortem Self-Efficacy
Change in nursing students' post-mortem self-efficacy will be measured using the End-of-Life and Post-Mortem Self-Efficacy Scale for Nursing Students. Total scores range from 0 to 100, with higher scores indicating greater self-efficacy in end-of-life and post-mortem care.
Time frame: Baseline, immediately after completion of the 2-month intervention (approximately 2 months), and 2-month follow-up (approximately 4 months from baseline).
Death Literacy
Change in nursing students' death literacy measured using the Death Literacy Index. Total scores range from 29 to 145, with higher scores indicating higher levels of death literacy.
Time frame: Baseline, immediately after completion of the 2-month intervention (approximately 2 months), and 2-month follow-up (approximately 4 months from baseline).
Attitudes Toward the Principles of a Dignified Death
Change in nursing students' attitudes toward the principles of a dignified death measured using the Attitudes Toward the Principles of a Dignified Death Scale. Total scores range from 12 to 60, with higher scores indicating greater endorsement of the principles of a dignified death.
Time frame: Baseline, immediately after completion of the 2-month intervention (approximately 2 months), and 2-month follow-up (approximately 4 months from baseline).
Plan to share: No
Start is estimated for Feb 2027; primary completion for Jun 2027, 4 months later.
Of 105 non-industry interventional studies with no phase under Death, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 48. This study's planned 4 months is below that.
Counting every sponsor, half of 109 studies reached it within 24 months; a quarter within 14 and three quarters within 48.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Necmettin Erbakan University →